Norway· NO-ID_1A00A0C4-8C19-4BE9-94CC-C37D0C98B532
Jyseleca
A filgotinib product containing filgotinib, registered in Norway by Alfasigma S.p.A. The same ATC class is registered in 10 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Filgotinib is registered in 10 of 19 countries.
Countries holding a registration under ATC L04AF04 (filgotinib), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 6 of them publish a price we can compare per daily dose
Filgotinib · ATC L04AF04
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
FEST (Norway)- Active substance
- Filgotinib
- Manufacturer
- Alfasigma S.p.A
- Country
- Norway (NO)
- ATC code
- L04AF04
- ATC class
- Filgotinib
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_1A00A0C4-8C19-4BE9-94CC-C37D0C98B532
- no_varenummer06730930NOK 12681.7
- gtin8020030001534
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Filgotinib in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaJYSELECAAlfasigma S.p.A., Bologna
- SpainJYSELECA 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULAAlfasigma S.P.A.
- FinlandJyselecaALFASIGMA S.p.A.
- FranceJYSELECA 100 mg, comprimé pelliculéALFASIGMA (ITALIE)
- IrelandJyseleca 100 mg film-coated tabletsAlfasigma S.p.A
- IcelandJyselecaAlfaSigma S.p.A.
- NetherlandsJyseleca 100 mg, filmomhulde tablettenAlfasigma S.p.A.
- PolandJyselecaAlfasigma S.p.A.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Jyseleca
- Liechtenstein · Jyseleca
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/49b117a0-307e-426e-acc4-7b2b19007f89 GET /v1/drugs/49b117a0-307e-426e-acc4-7b2b19007f89?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett, filmdrasjert",
"source": "fest",
"status": "A",
"atc_name": "Filgotinib",
"merkevare_id": "ID_1A00A0C4-8C19-4BE9-94CC-C37D0C98B532",
"name_form_strength": "Jyseleca tab 100 mg",
"prescription_group": "C"
}See everything about filgotinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.